Abstract:Many transcription factors play a key role in cellular differentiation and the delineation of cell phenotype. Transcription factors are regulated by phosphorylation, ubiquitination, acetylation/deacetylation and interactions between two or more proteins controlling multiple signaling pathways. These pathways regulate different physiological processes and pathological events, such as cancer and other diseases. The Forkhead box O (FOXO) is one subfamily of the fork head transcription factor family with important roles in cell fate decisions and this subfamily is also suggested to play a pivotal functional role as a tumor suppressor in a wide range of cancers. During apoptosis, FOXOs are involved in mitochondria-dependent and -independent processes triggering the expression of death receptor ligands like Fas ligand, TNF apoptosis ligand and Bcl‑XL, bNIP3, Bim from Bcl-2 family members. Different types of growth factors like insulin play a vital role in the regulation of FOXOs. The most important pathway interacting with FOXO in different types of cancers is the PI3K/AKT pathway. Some other important pathways such as the Ras-MEK-ERK, IKK and AMPK pathways are also associated with FOXOs in tumorigenesis. Therapeutically targeting the FOXO signaling pathway(s) could lead to the discovery and development of efficacious agents against some cancers, but this requires an enhanced understanding and knowledge of FOXO transcription factors and their regulation and functioning. This review focused on the current understanding of cell biology of FOXO transcription factors which relates to their potential role as targets for the treatment and prevention of human cancers. We also discuss drugs which are currently being used for cancer treatment along with their target pathways and also point out some potential drawbacks of those drugs, which further signifies the need for development of new drug strategies in the field of cancer treatment.

FoxO family members in cancer

FOXN Transcription Factors: Regulation and Significant Role in Cancer

FOXN Transcription Factors: Regulation and Significant Role in Cancer.

FOXO Signaling Pathways as Therapeutic Targets in Cancer

Akt, FoxO and regulation of apoptosis

The FOXO3-FOXM1 axis: A key cancer drug target and a modulator of cancer drug resistance

Mechanisms Controlling the Anti-Neoplastic Functions of FoxO Proteins.

Molecular and Cellular Pathobiology FoxO Transcription Factors Promote AKT Ser 473 Phosphorylation and Renal Tumor Growth in Response to Pharmacologic Inhibition of the PI 3 K – AKT Pathway

Dynamic FoxO transcription factors

mTORC2 Is the Major Second Layer Kinase Negatively Regulating FOXO3 Activity

Supplementary Methods and Figures Legends from FoxO Transcription Factors Promote AKT Ser473 Phosphorylation and Renal Tumor Growth in Response to Pharmacologic Inhibition of the PI3K–AKT Pathway

Members of FOX Family Could Be Drug Targets of Cancers

FOXO transcription factor family in cancer and metastasis

FOXO3a-interacting proteins' involvement in cancer: a review

Progress on the Role of FOX Family Genes in Oncogenesis

Progress in Research of FOXO Proteins in Tumorigenesis

FOXM1 and Cancer: Faulty Cellular Signaling Derails Homeostasis

Role of Forkhead Box Class O proteins in cancer progression and metastasis

The FOXO family of transcription factors: key molecular players in gastric cancer

The rules and regulatory mechanisms of FOXO3 on inflammation, metabolism, cell death and aging in hosts

Therapeutic strategies targeting FOXO transcription factors